Howard A. Fine, M.D.

Director of Neuro-oncology
Director, Brain Tumor Center, Sandra and Edward Meyer Cancer Center

Dr. Howard A. Fine is a neuro-oncologist on the faculty of both the department of neurological surgery and the department of neurology. Dr. Fine is Director of the Brain Tumor Center in the Sandra and Edward Meyer Cancer Center and Associate Director for the Translational Research of the Weill Cornell Brain Tumor Center. He is also Chief of the Division of Neuro-Oncology in the Department of Neurology.

Dr. Fine received his medical degree at the Mount Sinai School of Medicine in New York City, completed an internship and residency in Internal Medicine at the University of Pennsylvania in Philadelphia, and a fellowship in Medical Oncology at the Dana-Farber Cancer Institute and Harvard Medical School in Boston. Dr. Fine founded and Directed the Dana-Farber Cancer Institute Center for Neuro-Oncology at Harvard Medical School, and the Neuro-Oncology Branch, at the National Institutes of Health.  Dr. Fine most recently served as Chief of the Division of Hematology and Oncology and as Deputy Director of the New York University Cancer Center

Dr. Fine has a distinguished history of clinical and research work exclusively devoted to patients with brain tumors.  He has run a basic and translational science laboratory continuously for nearly 30 years and has been involved in well over 100 brain tumor clinical trials.  Dr. Fine has authored more than 200 scholarly articles, reviews, and book chapters in subjects all devoted to neuro-oncology/ brain tumors.


14 Faculty Members Named to List of New York SuperDoctors
These elite physicians are selected by their peers each year as being the best in their field
11 Weill Cornell Medicine Neurosurgery Faculty Members Selected to 2018 List of New York SuperDoctors
The annual list, published each May in the New York Times Magazine, is assembled based on peer nomination, credentials, and achievement.
Fortunately for Stephanie her tumor was low grade, with a much better prognosis than many other types of gliomas. “When treating brain tumors, we often deal with glioblastoma, which is a more serious matter,” says Dr. Ramakrishna. “But once we saw...

Weill Cornell Medicine Neurological Surgery 525 East 68 Street, Box 99 New York, NY 10065 Phone: 866-426-7787